A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Results 1 to 5 of 5

Thread: Sister has Relapsed AML

  1. #1
    Newbie New User
    Join Date
    Nov 2013
    Posts
    5

    Sister has Relapsed AML

    My sister was diagnosed with Acute Myeloid Leukemia (AML) in September 2012, at age 53. Her prognosis wasn't particularly good since AML is an extremely aggressive form of Leukemia. She underwent induction chemotherapy, which achieved remission, followed by a stem cell transplant (SCT). I thank God that my mother had 4 children as I knew the chances of being a match were only 25%. It turned out I was her perfect match and was able to donate my stem cells to her.

    Over the following three months, her counts began to rise, indicating engraftment, which was the goal. Her bone marrow bioposy at 90 days post SCT showed 99% engraftment of my stem cells, which was great.

    She did extremely well in the following months and we were finally beginning to breathe a sigh of relief when suddenly three weeks ago she started feeling ill and weak. A bone marrow biopsy confirmed that the AML is back.

    She is back in the hospital, undergoing chemo again. Remission is more difficult to achieve at relapse. The doctor gave her a 20 - 30% survival rate with treatment (because she insisted on knowing). This round of chemo will be completed next week, at which time another bone marrow biopsy will be performed to determine if remission was achieved.

    In December, she'll be re-admitted to the hospital for another intensive round of chemo to eradicate her immune system in preparation for a second SCT, and I will again be the donor.

    This road is a long and difficult one and she is scared, as am I and my family. She is in a very dark place emotionally because she knows what is ahead and she is focused on the prognosis she has been given. We can't get her out of her current emotional state and I can't really blame her. It's tearing my heart out to see her this way and to know what she has to endure again.

    I've done my research and I know the the grim prospects, but I need to be positive for her, and that's why I'm here. I need to share with people who have been through this and can offer some hope and support. And I hope I can offer some in return.

    I'm scared for my sister and can't bear the thought of losing her. I pray that my stem cells will work long-term this time, as I don't think there is much more they can do if this doesn't work.

    Prayers and words of encouragement would be appreciated.

    God bless you all.
    Last edited by amc422; 11-08-2013 at 10:27 PM.

  2. #2
    Super Moderator Top User po18guy's Avatar
    Join Date
    Feb 2012
    Posts
    10,448
    Welcome, but I truly wish it was under better circumstances. I would advise family to seek out and contact AML experts around the nation, and pick their brains as to the best course and the best facility for transplant. It almost appears as if she was not in complete remission at the time of the transplant. However, medical thinking is currently bending toward the concept of a cancer stem cell remaining somewhere in the body - but inactive. Something re-activates it at a later point in time and the malignancy develops, especially in those with compromised immune systems. Yet, she has yours! For this reason, it is thought, the exact same mutation may occur years, or even decades after the original malignancy. Since you are not a twin, the first transplant was an allogeneic, correct? Substantial radiation is normally involved with that. If so, how much more may she absorb from a second SCT? I think that it is time to shop around in the market of ideas regarding the best next move. All the best to all of you, and prayers are ascending.
    05/08-07/08 Tumor appears behind left ear. Followed by serial medical incompetence on the parts of PCP, veteran oncologist and pathologist (misdiagnosis via non-diagnosis). Providential guidance to proper care at an NCI designated comprehensive cancer center.
    07/08 Age 56 DX 1) Peripheral T-Cell Lymphoma-Not Otherwise Specified. Stage IV-B, >50 ("innumerable") tumors, bone marrow involvement.
    08/08-12/08 Four cycles CHOEP14 + four cycles GND (Cyclofosfamide, Doxorubicin, Vincristine, Etoposide, Prednisone & Gemcitabine, Navelbine, Doxil)
    02/09 2) Relapse.
    03/09-06/13 Clinical trial of Romidepsin > long-term study. NED for 64 twenty-eight day cycles, dose tapered.
    07/13 3) Relapse, 4) Suspected Mutation.
    08/13-02/14 Romidepsin increased, stopped for lack of response. Watch & Wait.
    09/14 Relapse/Progression. Visible cervical nodes appear within 4 days of being checked clear.
    10/06/14 One cycle Belinostat. Discontinued to enter second clinical trial.
    10/25/14 Clinical trial of Alisertib/Failed - Progression.
    01/12/15 Belinostat resumed/Failed - Progression. 02/23/15
    02/24/15 Pralatrexate/Failed - Progression. 04/17/15
    04/15 Genomic profiling reveals mutation into PTCL-NOS + AngioImmunoblastic T-Cell Lymphoma. Stage IV-B a second time. Two dozen tumors + small intestine (Ileum) involvement.
    04/22/15 TEC (Bendamustine, Etoposide, Carboplatin). Full response in two cycles. PET/CT both clear. Third cycle followed.
    06/15-07/15 Transplant preparation (X-rays, spinal taps, BMB, blood test, MUGA scan, lung function, CMV screening, C-Diff testing etc. etc. etc.) Intrathecal Methotrexate during spinal tap.
    BMB reveals 5) 26% blast cells of 20q Deletion Myelodysplastic Syndrome MDS), a bone marrow cancer and precursor to Acute Myeloid Leukemia.
    07/11-12/15 Cyclofosfamide + Fludarabine conditioning regimen.
    07/16/15 Total Body Irradiation.
    07/17/15 Moderate intensity Haploidentical Allogeneic Stem Cell Transplant receiving my son's peripheral blood stem cells.
    07/21-22/15 Triple dose Cyclofosfamide + Mesna, followed by immunosuppressants Tacrolimus and Mycophenolate Mofetil.
    07/23-08/03/15 Marrow producing zero blood cells. Fever. Hospitalized two weeks.
    08/04/15 Engraftment occurs, and blood cells are measurable - released from hospital.
    08/13/15 Day 26 - Marrow is 100% donor cells. Platelets climbing steadily, red cells follow.
    09/21/15 Acute skin Graft versus Host Disease arrives.
    DEXA scan reveals Osteoporosis.
    09/26/-11/03/15 Prednisone to control skin GvHD.
    11/2015 Acute GvHD re-classified to Chronic Graft versus Host Disease.
    05/2016 Tacrolimus stopped. Prednisone from 30-90mg daily tried. Sirolimus begun. Narrow-band UV-B therapy started, but discontinued for lack of response. One treatment of P-UVAreceived, but halted due to medication reaction.
    09/16/16 Three skin punch biopsies.
    11/04/16 GvHD clinical trial of Ofatumumab (Arzerra) + Prednisone + Methylprednisolone begun.
    12/16 Type II Diabetes, Hypertension - both treatment-related.
    05/17 Extracorporeal Photopheresis (ECP) begun in attempt to control chronic Graft-versus-Host-Disease (cGvHD. 8 year old Power Port removed and replaced with Vortex (Smart) Port for ECP.
    05/2017 Chronic anemia (low hematocrit). Chronic kidney disease. Cataracts from radiation and steroids.
    06/17 Trying various antibiotics in a search for tolerable prophylaxis.
    08/17 Bone marrow biopsy reveals the presence of 2% cells with 20q Deletion Myelodysplastic Syndrome, considered to be Minimum Residual Disease.
    12/17 Bone marrow biopsy reveals no abnormalities in the marrow - MDS eradicated. The steroid taper continues.
    01/18 Consented for Kadmon clinical trial.
    03/18 Began 400mg daily of KD025, a rho-Associated Coiled-coil Kinase 2 Inhibitor (ROCK2).
    09/18 Due to refractory GvHD, Extracorporeal Photopheresis halted after 15 months ue to lack of additional benefit.
    10/18 I was withdrawn from the Kadmon KD025 clinical trial due to increasing fatigue/lack of benefit.
    11/18 Began therapy with Ruxolitinib (Jakafi), a JAK 1&2 inhibitor class drug. Started at half-dose due to concerns with drug interactions.

    To date: 1 cancer, relapse, second relapse/mutation into 2 cancers, then 3 cancers simultaneously, 20 chemotherapy/GVHD drugs in 11 regimens (4 of them at least twice), 5 salvage regimens, 4 clinical trials, 5 post-transplant immuno-suppressant/modulatory drugs, the equivalent of 1,000 years of background radiation from 40+ CT series scans and about 24 PET scans.
    Both lymphoid and myeloid malignancies lend a certain symmetry to the hematological journey.

    Believing in the redemptive value of suffering makes all the difference.

  3. #3
    Newbie New User
    Join Date
    Nov 2013
    Posts
    5
    Dear po18guy,

    Thank you for your kind response and helpful information & recommendations.

    My sister did not have any radiation. She had three phases of chemo. The first was induction therapy, an intensive round of chemo meant to achieve remission. The second was consolidation therapy (a weaker form of chemo) to eradicate any cancer cells that might have remained under the radar. Remission was confirmed at that time via bone marrow biopsy. The third was another intensive round of chemo to kill her immune system in preparation for her stem cell transplant. The transplant was, indeed, allogenic.

    I will share this with my sister.

    Prayers and best wishes also for you.

  4. #4
    Super Moderator Top User po18guy's Avatar
    Join Date
    Feb 2012
    Posts
    10,448
    Radiation is used to kill whatever cells are left, in many cases. Chemo is not always 100% effective, and for that reason, radiation is often used. But, it comes at a price, as well. With a compromised immune system, only one cancer cell has to survive to set the stage for a relapse. And, the general threshold for cancer detection is one million cells - but bone marrow is different. Still, it seems that something survived in her marrow.
    05/08-07/08 Tumor appears behind left ear. Followed by serial medical incompetence on the parts of PCP, veteran oncologist and pathologist (misdiagnosis via non-diagnosis). Providential guidance to proper care at an NCI designated comprehensive cancer center.
    07/08 Age 56 DX 1) Peripheral T-Cell Lymphoma-Not Otherwise Specified. Stage IV-B, >50 ("innumerable") tumors, bone marrow involvement.
    08/08-12/08 Four cycles CHOEP14 + four cycles GND (Cyclofosfamide, Doxorubicin, Vincristine, Etoposide, Prednisone & Gemcitabine, Navelbine, Doxil)
    02/09 2) Relapse.
    03/09-06/13 Clinical trial of Romidepsin > long-term study. NED for 64 twenty-eight day cycles, dose tapered.
    07/13 3) Relapse, 4) Suspected Mutation.
    08/13-02/14 Romidepsin increased, stopped for lack of response. Watch & Wait.
    09/14 Relapse/Progression. Visible cervical nodes appear within 4 days of being checked clear.
    10/06/14 One cycle Belinostat. Discontinued to enter second clinical trial.
    10/25/14 Clinical trial of Alisertib/Failed - Progression.
    01/12/15 Belinostat resumed/Failed - Progression. 02/23/15
    02/24/15 Pralatrexate/Failed - Progression. 04/17/15
    04/15 Genomic profiling reveals mutation into PTCL-NOS + AngioImmunoblastic T-Cell Lymphoma. Stage IV-B a second time. Two dozen tumors + small intestine (Ileum) involvement.
    04/22/15 TEC (Bendamustine, Etoposide, Carboplatin). Full response in two cycles. PET/CT both clear. Third cycle followed.
    06/15-07/15 Transplant preparation (X-rays, spinal taps, BMB, blood test, MUGA scan, lung function, CMV screening, C-Diff testing etc. etc. etc.) Intrathecal Methotrexate during spinal tap.
    BMB reveals 5) 26% blast cells of 20q Deletion Myelodysplastic Syndrome MDS), a bone marrow cancer and precursor to Acute Myeloid Leukemia.
    07/11-12/15 Cyclofosfamide + Fludarabine conditioning regimen.
    07/16/15 Total Body Irradiation.
    07/17/15 Moderate intensity Haploidentical Allogeneic Stem Cell Transplant receiving my son's peripheral blood stem cells.
    07/21-22/15 Triple dose Cyclofosfamide + Mesna, followed by immunosuppressants Tacrolimus and Mycophenolate Mofetil.
    07/23-08/03/15 Marrow producing zero blood cells. Fever. Hospitalized two weeks.
    08/04/15 Engraftment occurs, and blood cells are measurable - released from hospital.
    08/13/15 Day 26 - Marrow is 100% donor cells. Platelets climbing steadily, red cells follow.
    09/21/15 Acute skin Graft versus Host Disease arrives.
    DEXA scan reveals Osteoporosis.
    09/26/-11/03/15 Prednisone to control skin GvHD.
    11/2015 Acute GvHD re-classified to Chronic Graft versus Host Disease.
    05/2016 Tacrolimus stopped. Prednisone from 30-90mg daily tried. Sirolimus begun. Narrow-band UV-B therapy started, but discontinued for lack of response. One treatment of P-UVAreceived, but halted due to medication reaction.
    09/16/16 Three skin punch biopsies.
    11/04/16 GvHD clinical trial of Ofatumumab (Arzerra) + Prednisone + Methylprednisolone begun.
    12/16 Type II Diabetes, Hypertension - both treatment-related.
    05/17 Extracorporeal Photopheresis (ECP) begun in attempt to control chronic Graft-versus-Host-Disease (cGvHD. 8 year old Power Port removed and replaced with Vortex (Smart) Port for ECP.
    05/2017 Chronic anemia (low hematocrit). Chronic kidney disease. Cataracts from radiation and steroids.
    06/17 Trying various antibiotics in a search for tolerable prophylaxis.
    08/17 Bone marrow biopsy reveals the presence of 2% cells with 20q Deletion Myelodysplastic Syndrome, considered to be Minimum Residual Disease.
    12/17 Bone marrow biopsy reveals no abnormalities in the marrow - MDS eradicated. The steroid taper continues.
    01/18 Consented for Kadmon clinical trial.
    03/18 Began 400mg daily of KD025, a rho-Associated Coiled-coil Kinase 2 Inhibitor (ROCK2).
    09/18 Due to refractory GvHD, Extracorporeal Photopheresis halted after 15 months ue to lack of additional benefit.
    10/18 I was withdrawn from the Kadmon KD025 clinical trial due to increasing fatigue/lack of benefit.
    11/18 Began therapy with Ruxolitinib (Jakafi), a JAK 1&2 inhibitor class drug. Started at half-dose due to concerns with drug interactions.

    To date: 1 cancer, relapse, second relapse/mutation into 2 cancers, then 3 cancers simultaneously, 20 chemotherapy/GVHD drugs in 11 regimens (4 of them at least twice), 5 salvage regimens, 4 clinical trials, 5 post-transplant immuno-suppressant/modulatory drugs, the equivalent of 1,000 years of background radiation from 40+ CT series scans and about 24 PET scans.
    Both lymphoid and myeloid malignancies lend a certain symmetry to the hematological journey.

    Believing in the redemptive value of suffering makes all the difference.

  5. #5
    Newbie Regular User
    Join Date
    Dec 2013
    Posts
    14
    Hi amc422,

    I hope you and your sister are doing ok.A second BMT is on the cards for me too.

    Best wishes to you and your family,
    Alyssa.

 

Similar Threads

  1. early relapsed all after transplant
    By meangene in forum Leukemia/Myelodysplastic Syndrome Forum
    Replies: 0
    Last Post: 02-02-2013, 11:31 PM
  2. New to the forum - relapsed DLBCL now CNSL
    By navybsn in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 9
    Last Post: 11-15-2012, 08:57 AM
  3. Chemo Type for Relapsed HL - ICE or something else?
    By RockyMiranda in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 5
    Last Post: 04-08-2011, 03:50 PM
  4. Panobinostat for relapsed Hodgkins
    By vg in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 0
    Last Post: 05-13-2010, 10:40 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •